Results: An Artisan myopia lens was implanted in 60 eyes of 36 patients with preoperative myopia ranging from -5.0 to -24.0 D. Mean patient age was 22.6 years. Mean spherical equivalent of manifest refraction stabilized by the first postoperative week. At three months follow-up, 54 eyes (90%) had a postoperative refraction within ± 1D emmetropia and 45 eyes (75%) had uncorrected visual acuity of 20/40 or better. Seven eyes (11.6%) had loss of one Snellen line and none had loss of two Snellen lines or more at three months. The mean endothelial cell loss was 3.8% at three months, 5.2% at six months, 5.25% at 12 months and 6.38% at two years, which was not significant. Postoperative complications included anterior chamber reaction in two eyes (3.3%), rise in intraocular pressure in six eyes (10%) and dislocation of PIOL in two eyes (3.3%).
A retrospective analysis of the first Indian experience on Artisan phakic intraocular lens
Lasik is the most widely performed procedure for correction of myopia. 1 At our center, the rejection rate for lasik stands at 33%, the most common cause being thin cornea. Alternatives to lasik include implantation of a phakic intraocular lens (PIOL) and refractive lens exchange.
Strampelli and Barraquer introduced PIOLs in the 1950s
to correct refractive errors. [1] [2] [3] Artisan phakic IOLs provide satisfactory results in refractive surgery for correction of myopia, hyperopia and astigmatism. 1, 2 The advantages of this procedure are preservation of accommodation, better quality of vision, potential reversibility of this procedure and stability and predictability of refractive outcome. The potential risks are cataract development, [1] [2] [3] sub-clinical intraocular inflammation, [3] [4] [5] endothelial cell loss, 3, [6] [7] [8] [9] intraocular pressure (IOP) rise [10] [11] [12] and risk of retinal detachment. 3, 13 To our knowledge, there is no Indian data published on anterior chamber iris supported PIOLs (Pubmed Search).
The aim of the study was to evaluate the clinical and refractive results of Artisan phakic IOLs (Ophtec BV,
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Groningen, The Netherlands) implanted in patients with high myopia.
Materials and Methods
A retrospective analysis of all patients who underwent Artisan phakic IOL implantation at our center between January 2002 and July 2003 was performed. A total of 60 eyes of 36 patients with follow-up of at least 24 months were included. The same surgeon (KPR) performed all surgical procedures at our hospital. A signed informed consent was taken from all patients before the procedure.
Patients >18 years of age with stable refractive error for at least one year and anterior chamber depth >2.9 mm, endothelial cell count >2000/mm 2 , IOP <20 mmHg and not suitable for Lasik due to thin cornea were offered this procedure. Patients with corneal pathology, uveitis, glaucoma, maculopathy or retinopathy and those with previous corneal or intraocular surgery were not considered for this procedure.
A complete preoperative ocular examination was done on all patients, including an A scan biometry (BioMedix Optotechnik and Devices, Echorule 1, Bangalore, India), Goldmann applanation tonometry (Haag Streit, Bern, Switzerland), keratometry and pachymetry (Orbscan II, Version 3, Bausch and Lomb, Rochester, NY) and endothelial cell count (Topcon 2000-p, Tokyo, Japan). The preoperative refraction required for calculating the power of the intraocular lens (IOL) was performed with and without cycloplegia (cyclopentolate hydrochloride 1.0%). Best spectacle corrected visual acuity (BSCVA) was measured before and after surgery. Dilated fundus examination including peripheral retinal screening was done. Three months prior to surgery, all patients underwent peripheral pan retinal photocoagulation (PPRP) of the peripheral retina with Argon Green Laser (Iris medical Oculight GL/GLX 532 nm). In this procedure, two rows of laser burns were applied to 360° periphery with extra coverage given for peripheral lattice and holes.
The Artisan myopia lenses used in our patients were convex-concave (models 206 and 204) iris fixated IOLs, designed by Jan Worst and manufactured by Ophtec BV, Groningen, The Netherlands. The overall length of the lens was 8.5 mm. The optic is manufactured in diameters of 5 and 6 mm. The 6 mm lens is available from -3 to -15.5 diopter (D) in half D steps and the 5 mm lens from -3 to -23.0 D in half D steps. Both lens designs are exactly the same and differ only in optical diameter and effective optical zone size. The height of either lenses does not exceed 0.95 mm.The power of the lens was calculated with the Van der Heijde's formula 14 and was based on the refractive power of the cornea (mean corneal curvature, K), adjusted anterior chamber depth (ACD) and the patients spherical equivalent refractive error (spectacle correction at a 12.0-mm vertex).
The surgery was performed under peribulbar anesthesia with 2.5 ml marcaine and 2.5 ml lidocaine with hyaluronidase 150 IU in 34 patients and general anesthesia in two patients. One drop of 2% pilocarpine was instilled in the morning and 30 min prior to surgery.
The surgical protocol was the same for all patients. Two side port incisions were made at 2 o'clock and 11 o'clock positions. The anterior chamber was filled with Hyvisc plus (sodium hyaluronate solution, 14 mg/ml, Unimed Technologies Ltd. Halol, Gujarat). A clear corneal limbal incision of 6mm was made at 12 o'clock. The Artisan myopia lens was then introduced toward the 6 o'clock position, using a special forceps (Duckworth and Kent Ltd. Baldock Herts, England) designed for the claw lens. The lens was rotated using a lens rotator such that the haptics were at 3 and 9 o'clock positions. The PIOL was then held with a Budo forceps (Duckworth and Kent Ltd. Baldock Herts, England) at the outer part of the optic and the enclavation needle (Ophtec BV, Groningen, The Netherlands) passed through the paracenteces and iris tissue was enclavated [ Fig. 1 ]. A peripheral iridectomy was performed with vannas scissors. After removing the viscoelastic from the anterior chamber the wound was closed with 10.0 nylon. Subconjunctival gentamicin was administered.
Postoperatively, prednisolone acetate eye drops 1%, six times daily tapering over four weeks and ofloxacin 0.3% (Nicholas Piramal India Ltd. Madhya Pradesh, India) eye drops four times daily for one week were used. Follow-up examinations were performed at one day, one week, three weeks, two-four months, six months and 12 months and annually thereafter. Patients with complications were examined more frequently. Statistically significant differences between the means of the data samples were determined by one-way analysis of variance (ANOVA) and Kruskal-Wallis test. A probability value <0.05 was considered statistically significant.
Results
Our patient population included 15 men and 21 women with a mean age of 22.6 ± 3.6 years (range: 18-32 years). All patients were followed up for 24 months. Preoperative myopia ranged from -5. The endothelial cell count loss postoperatively [ Fig. 7 In our study, postoperative complications included iritis, IOP rise and dislocation of IOL. Anterior uveitis was observed in two eyes (3%) of which one eye had an inflammatory membrane with hypopyon. Both responded well to topical and sub-conjuctival steroids and resolved completely. There was rise in IOP in six eyes (10%). In one eye IOP rise occurred in the first week after surgery, during the third to fourth postoperative weeks in three eyes and in the sixth postoperative week in two eyes. All of them were started on anti-glaucoma medication. As these eyes were thought to be steroid responders, the strength and dose of steroids were also reduced (fluoromethalone 0.1% starting four times daily and tapered over four weeks). In five eyes we were able to stop all the anti-glaucoma medication by 8-12 weeks. In one eye, there were intermittent spikes of high IOP with corneal edema and IOP was not controlled with maximal medical therapy. As the disc started showing glaucomatous damage the PIOL was explanted and clear lens extraction with trabeculectomy was done.
In two eyes, dislocation of PIOL occurred following trauma. In one eye, one haptic was dislocated which was repositioned surgically. One eye had dislocation of both haptics. The PIOL was explanted and clear lens extraction was performed in the same sitting.
Discussion
The primary outcome measure used to assess the effectiveness of refractive surgery was unaided postoperative visual acuity. 15, 16 In our study, at three months, 45 eyes (75%) achieved UCVA of 20/40 or better, which is comparable to 73.4% and 79.6% respectively in Landesz et al. 6 and Benedetti et al. 16 Secondary outcome measures included postoperative refraction within ± 0.5 to ± 1.0 D, postoperative astigmatism and mean endothelial cell loss. In our series, 44 eyes (73.3%) had postoperative refraction within ± 0.5D, 54 eyes (90%) within ± 1D and 59 eyes (98.3%) within ± 2D. This was better compared to other published series where the postoperative refraction within ± 1 D ranged from 62.1% to 79.8%. 14, 16, 17 In the US FDA study, 65% had a postoperative refraction of ± 0.5D and 93% within ± 1D. 17 Mean preoperative astigmatism in our study was -1.61D ± 1.07D. By three months, the astigmatism had reduced to -0.4 ± 0.65 D. This was comparable to other studies where preoperative astigmatism of 1.12 ± 0.8 D had reduced to 0.82 ± 0.62 D. 18 In our study, seven eyes (11.6%) had loss of one Snellen line of visual acuity and there was no loss of two or more Snellen lines in any patient. Fifty-three eyes (88.3%) had either no loss or gained one or more lines of visual acuity. In comparison, the US FDA study showed that 5% of eyes lost one line and 95% had either no loss or gained one line or more. 17 The efficacy index in our series was 0.93 that was comparable to two other published studies 2, 16 where the values were 0.93 and 0.84 respectively. Our safety index was 1.19, which was less than 1.31 reported by Budo et al. 2 and 1.12 and 1.39 in high and low myopia respectively reported by Benedetti et al. 16 The mean endothelial cell loss in our series was 3.8% at three months, 5.2% at six months, 5.25% at 12 months and 6.38% at two years. The cell loss was more in the first few cases reflecting our learning curve. Some cases also showed a gain in endothelial cell density postoperatively. As reported by Landesz et al, the variation in cell density measurement in healthy eyes ranged from 1.4 to 14.3 % with a mean of 6.2%. 6 Several studies with Artisan iris claw lens implantation reported endothelial damage and cell loss ranging from 6.5-13% at one year and 9.2-17.6% at two years. 7, [19] [20] [21] [22] [23] In our study, mean endothelial cell loss was similar to or lower than previously reported. Intraoperative complications like hyphema, traumatic cataract or iris prolapse were not encountered.
IOP rise was noted in six eyes (10%). After implantation of PIOLs, IOP rise can be caused by pupillary block, retained viscoelastic in the anterior chamber, decreased aqueous drainage due to trabecular mesh work block by fibrin, pigments and steroid responsiveness. 24 In five eyes the IOP was controlled medically and they were off medication within two-three months. In one eye with medically uncontrolled glaucoma, explantation of PIOL was done with clear lens extraction and trabeculectomy.
In our series, of the first four eyes that had a YAG peripheral iridotomy (PI) preoperatively, three eyes developed raised IOP postoperatively. Apart from retained viscoelastics after implantation of PIOL, increased pigment release following YAG PI in dark brown and black irides in the Indian population could be a possible cause. As our surgical skill and experience improved, we started doing a surgical PI instead of YAG PI and irrigation and aspiration was done thoroughly in all cases. Since then, we have noticed a decrease in the incidence of raised IOP postoperatively.
Postoperative iritis was noted in two eyes (3%). Inflammatory reaction in various studies ranged from 0-9.3%. 3, 16 An important complication associated with PIOLs is retinal detachment.
3,4,13, 14 We did not encounter any retinal detachment. Fencher et al. 15 reported an incidence of 0.8% with iris-clipped PIOLs and Alio et al. 4 reported 4.45% incidence with angle-supported PIOLs.
In our series all patients underwent prophylactic PPRP. 25 This procedure was done at least two-three months prior to surgery, to ensure good adhesion. We attribute the absence of postoperative retinal detachment to prophylactic PPRP. However, the efficacy of this procedure as a routine in all patients to prevent postoperative retinal detachment needs to be studied prospectively.
Glare or halos, which affect night vision and driving, is an important consideration in PIOL implantation. In our series, none experienced this complication, probably because Indian eyes have smaller pupil size compared to Caucasians. Other studies reported glare/haloes ranging from 6-8.8%. 2, 16 Other complications like iris atrophy, 16, 26 iris perforation, 16 cataract development, 2,5 cystic wounds, 3 Urrets Zavalia syndrome, 27, 28 vitreous hemorrhage, 29 ischemic optic neuropathy 30 and choroidal neovascularization, 31 were not found in our series. Same surgeon performing all the procedures is the strength of the study. However, retrospective data, study from a single institution and possible bias are the limitations of the present study.
Conclusion
Our study results support the efficacy of phakic IOL as a refractive surgical procedure for correction of high myopia. It resulted in stable improvement in both UCVA and BSCVA over a two-year period with a few complications. The role of PPRP as a prophylactic procedure to prevent postoperative retinal detachment and whether surgical PI results in lower incidence of postoperative IOP rise compared to YAG PI need to be studied prospectively. Longer follow-up is necessary to monitor for late complications.
